College of American Pathologists Challenges FDA LDT Regulation With Amicus Brief Filing
October 08, 2024
October 08, 2024
NORTHFIELD, Illinois, Oct. 8 (TNSres) -- The College of American Pathologists issued the following news release:
The College of American Pathologists (CAP) filed an amicus brief on October 7 in a U.S. District Court against the Food and Drug Administration (FDA) and its regulation of laboratory-developed tests (LDTs). The CAP joined the American Clinical Laboratory Association (ACLA) and the Association for Molecular Pathology (AMP) in challenging the LDT rulemaking by the FDA, whic . . .
The College of American Pathologists (CAP) filed an amicus brief on October 7 in a U.S. District Court against the Food and Drug Administration (FDA) and its regulation of laboratory-developed tests (LDTs). The CAP joined the American Clinical Laboratory Association (ACLA) and the Association for Molecular Pathology (AMP) in challenging the LDT rulemaking by the FDA, whic . . .